Fintel reports that on November 4, 2024, Argus Research upgraded their outlook for AbbVie (NYSE:ABBV) from Hold to Buy.

Under the auspices of the Saudi Society of Rheumatology, Saudi Society of Dermatology and Dermatologic Surgery, Saudi ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

On Friday, AbbVie Inc (ABBV) stock saw a decline, ending the day at $203.55 which represents a decrease of $-0.32 or -0.16% from the prior close of $203.87. The stock opened at $204.37 and touched a ...

The University of Chicago Medicine’s incoming cancer center is getting a new name thanks to a $75 million donation from the ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

Their discoveries have already led to the departure of a Stanford president, sparked charges from the Department of Justice, ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

CAMBRIDGE, MA: Takeda Pharmaceutical has hired Jane Woo as VP and head of research and development and portfolio ...

EvolveImmune Therapeutics Inc., a Branford-based bioscience company developing therapeutics to overcome cancer cell resistance to current immunotherapies, has signed a collaboration and ...

United Statescategory Michigan city of Warren in focus amid worries about delayed election results November 2, 2024 United Statescategory Harris and Trump locked in tight race in swing states, NYT ...

Kamala Harris and Donald Trump have framed the presidential race as an existential battle. Voters are heeding their warnings. 7 min read LIVE Harris and Trump Court Pennsylvania Voters in Final ...